ANEXATE

This brand name is authorized in Austria, Estonia, Spain, Hong Kong, Croatia, Ireland, Japan, Lithuania, Netherlands, New Zealand, Romania, Singapore

Active ingredients

The drug ANEXATE contains one active pharmaceutical ingredient (API):

1 Flumazenil UNII 40P7XK9392 - FLUMAZENIL

Flumazenil, an imidazobenzodiazepine, is a benzodiazepine antagonist which, by competitive interaction, blocks the effects of substances acting via the benzodiazepine-receptor. Neutralisation of paradoxal reactions of benzodiazepines has been reported. Read about Flumazenil

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V03AB25	Flumazenil	V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AB Antidotes
Discover more medicines within V03AB25

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1000584
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 57806, 57807
Country: HK	Department of Health Drug Office	Identifier(s): 30501
Country: JP	医薬品医療機器総合機構	Identifier(s): 2219403A1027
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1090497
Country: NL	Z-Index G-Standaard	Identifier(s): 13260251
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 25941
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 4284
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W63674001
Country: SG	Health Sciences Authority	Identifier(s): 01509P